Process and apparatus for vacuum distillation of high-purity magnesium
US-9677151-B2 · Jun 13, 2017 · US
US10995398B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10995398-B2 |
| Application number | US-201815933635-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 23, 2018 |
| Priority date | Jun 26, 2012 |
| Publication date | May 4, 2021 |
| Grant date | May 4, 2021 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A preferred embodiment is an uncoated, biodegradable stent. The stent has a filigree structure of magnesium alloy struts. The struts of the supporting structure are arranged to permit a compressed form for introduction into the body and to permit an expanded form at the site of the application within a vessel. The magnesium alloy struts are formed of a corrodible magnesium alloy. The magnesium alloy is formed from high-purity vacuum distilled magnesium containing impurities, which promote electrochemical potential differences and/or the formation of precipitations and/or intermetallic phases. The impurities are such that the struts of the stent have a tensile strength of >275 MPa a yield point of >200 MPa, a yield ratio of <0.8, a difference between tensile strength and yield point of >50 MPa.
Opening claim text (preview).
The invention claimed is: 1. A biodegradable stent, comprising a filigree structure of magnesium alloy struts, the struts of the filigree structure being arranged to permit a compressed form for introduction into the body and to permit an expanded form at the site of the application within a vessel; wherein the magnesium alloy struts consist of a corrodible magnesium alloy having 2.0 to 10.0% by weight Al and a remainder consisting of vacuum distilled magnesium containing impurities in a total amount of no more than 0.0063% by weight, the alloy having solid solutions of Al and intermetallic phases of magnesium and Al in the alloy matrix, the matrix lacking Mn as an alloying element to suppress formation of the ternary intermetallic phase FeMnSi and thereby improve corrosion resistance, wherein the struts of the stent have a tensile strength of >275 MPa a yield point of >200 MPa, a yield ratio of <0.8, and a difference between tensile strength and yield point of >50 MPa. 2. The biodegradable stent of claim 1 , wherein the magnesium alloy struts have a microstructure with a grain size of <5.5 μm. 3. The biodegradable stent of claim 2 , wherein the intermetallic phases are dispersedly distributed and have a 0.5 μm particle size. 4. The biodegradable stent of claim 1 , wherein the content of Al is 2.0 to 8.0% by weight. 5. The biodegradable stent of claim 1 , wherein the impurities total no more than 0.003% by weight. 6. The biodegradable stent of claim 1 , wherein the magnesium alloy struts have a fine-grained microstructure having a grain size of no more than 7.5 μm. 7. The biodegradable stent of claim 1 , wherein the magnesium alloy struts are uncoated by any polymer passivation layer or any metal or ceramic corrosion-inhibiting coating. 8. The biodegradable stent of claim 7 , wherein the stent is an active stent.
Related publications grouped by family.
Answers are generated from the same data shown on this page.